Brighton Jones LLC
IMNM icon

Brighton Jones LLC’s Immunome IMNM Stock Holding History

Brighton Jones LLC’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$223K Sell
10,545
-28
-0.3% -$599 ﹤0.01% 1199
2026
Q1 		$231K Buy
+10,573
New +$235K 0.01% 1029
2025
Q4 		– Sell
-10,513
Closed -$123K – 480
2025
Q3 		$123K Buy
10,513
+22
+0.2% +$219 ﹤0.01% 985
2025
Q2 		$97.6K Buy
+10,491
New +$86K ﹤0.01% 890
2024
Q2 		– Sell
-8,477
Closed -$209K – 652
2024
Q1 		$209K Buy
+8,477
New +$172K 0.01% 565

Other funds holding IMNM

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Driehaus Capital Management
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return

Brighton Jones LLC's IMNM Position: Q2 2026 in Review

Brighton Jones LLC reduced its Immunome (IMNM) stake by 0.26% in Q2 2026, selling an estimated $599 and leaving 10,545 shares worth $223K. The position accounts for ﹤0.01% of the portfolio, ranked #1199.

Brighton Jones LLC first reported a position in IMNM in Q1 2024 and has held it in 5 quarters since. The position peaked at $231K in Q1 2026. 202 funds tracked by Wall St. Rank hold IMNM as of Q2 2026.

  • Brighton Jones LLC held 10,545 shares of Immunome worth $223K as of Q2 2026.
  • Brighton Jones LLC sold 28 Immunome shares in Q2 2026, an estimated $599.
  • Immunome made up ﹤0.01% of Brighton Jones LLC's portfolio in Q2 2026, its #1199 holding.
  • Brighton Jones LLC first reported a position in Immunome in Q1 2024 and has held it in 5 quarters since.
  • Brighton Jones LLC's Immunome position peaked at $231K in Q1 2026.
  • 202 funds tracked by Wall St. Rank held Immunome as of Q2 2026.

Based on Brighton Jones LLC's 13F filing for Q2 2026, filed 11 Aug 2026.